microdosing tirzepatide vs semaglutide GLP-1 agonists—using doses below FDA-approved levels for T2D or obesity—is rapidly gaining traction as an off-label strategy to improve tolerability, tailor titration, and manage costs GLP-1s aren't just for weight

Understanding your genetic predispositions helps your PlexusDx provider tailor your dose escalation schedule, recommend timing strategies to minimize nausea, or suggest tirzepatide as an alternative if your GLP-1 genetic profile suggests lower sensitivity

But calling it a simple mimic undersells what happens at the molecular level

It enhances feelings of fullness and reduces hunger, helping individuals consume fewer calories

Document which site you used each week so you naturally spread injections across different areas without overlapping

number needed to treat = 121) 13% reduction in cardiovascular death (IRR 0.87